Plexpress, ValiRx deal

ValiRx acquired all Plexpress assets and IP, specifically its Transcript Analysis with the Aid of Affinity Capture (TRAC) gene expression and biomarker technology, for EUR75,000 ($85,080) in cash. Acc...